Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study.

ABSTRACT:

Background & aims

Information about the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with liver cancer is lacking. This study characterizes the outcomes and mortality risk in this population.

Methods

Multicentre retrospective, cross-sectional, international study of liver cancer patients with SARS-CoV-2 infection registered between February and December 2020. Clinical data at SARS-CoV-2 diagnosis and outcomes were registered.

Results

Two hundred fifty patients from 38 centres were included, 218 with hepatocellular carcinoma (HCC) and 32 with intrahepatic cholangiocarcinoma (iCCA). The median age was 66.5 and 64.5 years, and 84.9% and 21.9% had cirrhosis in the HCC and iCCA cohorts respectively. Patients had advanced cancer stage a

SUBMITTER: Munoz-Martinez S 

PROVIDER: S-EPMC9347559 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature